Lymphedema-induced lymphangiosarcoma.
Identifieur interne : 005405 ( PubMed/Curation ); précédent : 005404; suivant : 005406Lymphedema-induced lymphangiosarcoma.
Auteurs : A J Janse [Pays-Bas] ; F. Van Coevorden ; H. Peterse ; R B Keus ; J A Van DongenSource :
- European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology [ 0748-7983 ] ; 1995.
Descripteurs français
- KwdFr :
- MESH :
- diagnostic : Lymphangiosarcome.
- effets indésirables : Association thérapeutique.
- étiologie : Lymphangiosarcome, Lymphoedème.
- Adulte d'âge moyen, Femelle, Humains, Lymphangiosarcome, Lymphoedème, Mâle, Sujet âgé, Tumeurs du sein.
English descriptors
- KwdEn :
- Aged, Breast Neoplasms (complications), Breast Neoplasms (therapy), Combined Modality Therapy (adverse effects), Female, Humans, Lymphangiosarcoma (diagnosis), Lymphangiosarcoma (etiology), Lymphangiosarcoma (therapy), Lymphedema (complications), Lymphedema (congenital), Lymphedema (etiology), Male, Middle Aged.
- MESH :
- adverse effects : Combined Modality Therapy.
- complications : Breast Neoplasms, Lymphedema.
- congenital : Lymphedema.
- diagnosis : Lymphangiosarcoma.
- etiology : Lymphangiosarcoma, Lymphedema.
- therapy : Breast Neoplasms, Lymphangiosarcoma.
- Aged, Female, Humans, Male, Middle Aged.
Abstract
A series of eight patients with chronic lymphedema-related lymphangiosarcoma is presented. All but one case showed a typical rapid progression and fatal outcome, as has been reported in other series. In one patient the lymphangiosarcoma developed on the chest wall, the axilla and the arm where persisting lymphedema and fibrosis occurred after bilateral mastectomy and bilateral postoperative radiotherapy. In this patient an asymptomatic course and slow locoregional progression of lesions was seen. The clinical picture, the etiological considerations and the therapeutic options of the lymphedema-induced lymphangiosarcoma with regard to the literature are discussed.
PubMed: 7720889
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :005405
Links to Exploration step
pubmed:7720889Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Lymphedema-induced lymphangiosarcoma.</title><author><name sortKey="Janse, A J" sort="Janse, A J" uniqKey="Janse A" first="A J" last="Janse">A J Janse</name><affiliation wicri:level="3"><nlm:affiliation>Department of Surgery, The Netherlands Cancer Institute/Antoni van Leeuwenhoek ziekenhuis, Amsterdam.</nlm:affiliation><country>Pays-Bas</country><placeName><settlement type="city">Amsterdam</settlement><region nuts="2" type="province">Hollande-Septentrionale</region></placeName><wicri:orgArea>Department of Surgery, The Netherlands Cancer Institute/Antoni van Leeuwenhoek ziekenhuis</wicri:orgArea></affiliation></author><author><name sortKey="Van Coevorden, F" sort="Van Coevorden, F" uniqKey="Van Coevorden F" first="F" last="Van Coevorden">F. Van Coevorden</name></author><author><name sortKey="Peterse, H" sort="Peterse, H" uniqKey="Peterse H" first="H" last="Peterse">H. Peterse</name></author><author><name sortKey="Keus, R B" sort="Keus, R B" uniqKey="Keus R" first="R B" last="Keus">R B Keus</name></author><author><name sortKey="Van Dongen, J A" sort="Van Dongen, J A" uniqKey="Van Dongen J" first="J A" last="Van Dongen">J A Van Dongen</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="1995">1995</date><idno type="RBID">pubmed:7720889</idno><idno type="pmid">7720889</idno><idno type="wicri:Area/PubMed/Corpus">005405</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">005405</idno><idno type="wicri:Area/PubMed/Curation">005405</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">005405</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Lymphedema-induced lymphangiosarcoma.</title><author><name sortKey="Janse, A J" sort="Janse, A J" uniqKey="Janse A" first="A J" last="Janse">A J Janse</name><affiliation wicri:level="3"><nlm:affiliation>Department of Surgery, The Netherlands Cancer Institute/Antoni van Leeuwenhoek ziekenhuis, Amsterdam.</nlm:affiliation><country>Pays-Bas</country><placeName><settlement type="city">Amsterdam</settlement><region nuts="2" type="province">Hollande-Septentrionale</region></placeName><wicri:orgArea>Department of Surgery, The Netherlands Cancer Institute/Antoni van Leeuwenhoek ziekenhuis</wicri:orgArea></affiliation></author><author><name sortKey="Van Coevorden, F" sort="Van Coevorden, F" uniqKey="Van Coevorden F" first="F" last="Van Coevorden">F. Van Coevorden</name></author><author><name sortKey="Peterse, H" sort="Peterse, H" uniqKey="Peterse H" first="H" last="Peterse">H. Peterse</name></author><author><name sortKey="Keus, R B" sort="Keus, R B" uniqKey="Keus R" first="R B" last="Keus">R B Keus</name></author><author><name sortKey="Van Dongen, J A" sort="Van Dongen, J A" uniqKey="Van Dongen J" first="J A" last="Van Dongen">J A Van Dongen</name></author></analytic><series><title level="j">European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology</title><idno type="ISSN">0748-7983</idno><imprint><date when="1995" type="published">1995</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged</term><term>Breast Neoplasms (complications)</term><term>Breast Neoplasms (therapy)</term><term>Combined Modality Therapy (adverse effects)</term><term>Female</term><term>Humans</term><term>Lymphangiosarcoma (diagnosis)</term><term>Lymphangiosarcoma (etiology)</term><term>Lymphangiosarcoma (therapy)</term><term>Lymphedema (complications)</term><term>Lymphedema (congenital)</term><term>Lymphedema (etiology)</term><term>Male</term><term>Middle Aged</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte d'âge moyen</term><term>Association thérapeutique (effets indésirables)</term><term>Femelle</term><term>Humains</term><term>Lymphangiosarcome ()</term><term>Lymphangiosarcome (diagnostic)</term><term>Lymphangiosarcome (étiologie)</term><term>Lymphoedème ()</term><term>Lymphoedème (étiologie)</term><term>Mâle</term><term>Sujet âgé</term><term>Tumeurs du sein ()</term></keywords><keywords scheme="MESH" qualifier="adverse effects" xml:lang="en"><term>Combined Modality Therapy</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Breast Neoplasms</term><term>Lymphedema</term></keywords><keywords scheme="MESH" qualifier="congenital" xml:lang="en"><term>Lymphedema</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Lymphangiosarcoma</term></keywords><keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Lymphangiosarcome</term></keywords><keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Association thérapeutique</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Lymphangiosarcoma</term><term>Lymphedema</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Breast Neoplasms</term><term>Lymphangiosarcoma</term></keywords><keywords scheme="MESH" qualifier="étiologie" xml:lang="fr"><term>Lymphangiosarcome</term><term>Lymphoedème</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Aged</term><term>Female</term><term>Humans</term><term>Male</term><term>Middle Aged</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte d'âge moyen</term><term>Femelle</term><term>Humains</term><term>Lymphangiosarcome</term><term>Lymphoedème</term><term>Mâle</term><term>Sujet âgé</term><term>Tumeurs du sein</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">A series of eight patients with chronic lymphedema-related lymphangiosarcoma is presented. All but one case showed a typical rapid progression and fatal outcome, as has been reported in other series. In one patient the lymphangiosarcoma developed on the chest wall, the axilla and the arm where persisting lymphedema and fibrosis occurred after bilateral mastectomy and bilateral postoperative radiotherapy. In this patient an asymptomatic course and slow locoregional progression of lesions was seen. The clinical picture, the etiological considerations and the therapeutic options of the lymphedema-induced lymphangiosarcoma with regard to the literature are discussed.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">7720889</PMID><DateCreated><Year>1995</Year><Month>05</Month><Day>25</Day></DateCreated><DateCompleted><Year>1995</Year><Month>05</Month><Day>25</Day></DateCompleted><DateRevised><Year>2007</Year><Month>07</Month><Day>02</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0748-7983</ISSN><JournalIssue CitedMedium="Print"><Volume>21</Volume><Issue>2</Issue><PubDate><Year>1995</Year><Month>Apr</Month></PubDate></JournalIssue><Title>European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology</Title><ISOAbbreviation>Eur J Surg Oncol</ISOAbbreviation></Journal><ArticleTitle>Lymphedema-induced lymphangiosarcoma.</ArticleTitle><Pagination><MedlinePgn>155-8</MedlinePgn></Pagination><Abstract><AbstractText>A series of eight patients with chronic lymphedema-related lymphangiosarcoma is presented. All but one case showed a typical rapid progression and fatal outcome, as has been reported in other series. In one patient the lymphangiosarcoma developed on the chest wall, the axilla and the arm where persisting lymphedema and fibrosis occurred after bilateral mastectomy and bilateral postoperative radiotherapy. In this patient an asymptomatic course and slow locoregional progression of lesions was seen. The clinical picture, the etiological considerations and the therapeutic options of the lymphedema-induced lymphangiosarcoma with regard to the literature are discussed.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Janse</LastName><ForeName>A J</ForeName><Initials>AJ</Initials><AffiliationInfo><Affiliation>Department of Surgery, The Netherlands Cancer Institute/Antoni van Leeuwenhoek ziekenhuis, Amsterdam.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Coevorden</LastName><ForeName>F</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>Peterse</LastName><ForeName>H</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Keus</LastName><ForeName>R B</ForeName><Initials>RB</Initials></Author><Author ValidYN="Y"><LastName>van Dongen</LastName><ForeName>J A</ForeName><Initials>JA</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Eur J Surg Oncol</MedlineTA><NlmUniqueID>8504356</NlmUniqueID><ISSNLinking>0748-7983</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001943" MajorTopicYN="N">Breast Neoplasms</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003131" MajorTopicYN="N">Combined Modality Therapy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008204" MajorTopicYN="N">Lymphangiosarcoma</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008209" MajorTopicYN="N">Lymphedema</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000151" MajorTopicYN="N">congenital</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1995</Year><Month>4</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1995</Year><Month>4</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1995</Year><Month>4</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">7720889</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 005405 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 005405 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= PubMed
|étape= Curation
|type= RBID
|clé= pubmed:7720889
|texte= Lymphedema-induced lymphangiosarcoma.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:7720889" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |